WASHINGTON (Reuters) - Allergan PLC's Forest Laboratories and Forest Pharmaceuticals units will pay $38 million to settle U.S. charges that it paid physicians to prescribe three medications, the U.S. Justice Department said on Thursday.


In a statement, the department said the alleged kickbacks involved the companies' blood pressure hypertension drug Bystolic, fibromyalgia medication Savella and the Alzheimer’s disease product Namend.


(Reporting by Susan Heavey)